Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516686 | PMC |
| http://dx.doi.org/10.1038/bjc.2012.497 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report: Improving quality of life through hyaluronic acid-based fillers after orbital cancer treatment.
Front Oncol
December 2024
Department of Pediatrics, Sapienza University, Rome, Italy.
Background: Myoepithelial carcinoma is a very rare yet aggressive tumor in children. Surgical intervention and local radiotherapy often lead to post-therapy complications, affecting both the aesthetic and functional quality of life in survivors. Hyaluronic acid (HA) dermal fillers offer a minimally invasive option to improve the appearance and quality of life for these patients once they are declared tumor-free.
View Article and Find Full Text PDFUse of oxymetazoline hydrochloride ophthalmic solution, 0.1% for improved lid symmetry in Graves' disease.
Orbit
August 2024
Ophthalmology, Texas Ophthalmic Plastic, Reconstructive & Orbital Surgery Associates, Dallas, Texas, USA.
Purpose: The purpose of this study is to evaluate the usage of oxymetazoline hydrochloride ophthalmic solution, 0.1% in the treatment of Graves' disease to improve lid symmetry.
Methods: Fourteen patients were identified with unilateral upper eyelid retraction, secondary to Graves' disease.
Poly-L-lactic acid fillers for nasal alar retraction: safety and effectiveness in 13 cases.
Am J Transl Res
June 2024
Chengdu Ningyue FRESKIN Medical Cosmetology Clinic Co., LTD. Chengdu 610000, Sichuan, China.
Article Synopsis
- - A study evaluated the use of poly-L-lactic acid (PLLA) fillers for treating nasal alar retraction in 13 patients at a medical clinic in China between September 2022 and July 2023.
- - The patients showed significant improvement in severity scores from an average of 1.62 to 0.54 after treatment, indicating effective results.
- - All patients expressed satisfaction with the treatment, and no adverse effects or embolism risks were reported, suggesting PLLA fillers could be a safe option for wider clinical use.
Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease.
Front Ophthalmol (Lausanne)
May 2024
Division of Oculoplastic and Orbital Surgery, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
Purpose: To evaluate percutaneous triamcinolone (TA) injection efficacy in treating upper eyelid retraction (UER) for Australian thyroid eye disease (TED) patients.
Methods: We conducted a retrospective analysis across 8 years and multiple diverse Australian centres identified UER patients who received TA injections. A single operator administered 40mg/1ml TA through upper eyelid skin.
Soft Tissue Responses to Orthodontic Treatment: Impact of Premolar Extraction on Diverse Growth Patterns.
Cureus
April 2024
Department of Orthodontics and Dentofacial Orthopedics, Saveetha Institute of Medical and Technical Sciences, Chennai, IND.
Introduction: Alteration in facial soft tissue plays an important role in the esthetics of an individual. The first thing a patient wants from orthodontic treatment is how well he/she looks. The degree of soft tissue changes brought about by the retraction of teeth can be influenced by factors such as extraction pattern, muscle function, age, gender, weight, etc.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!